118 results on '"Tirolo, C."'
Search Results
2. Stress, glucocorticoids and the susceptibility to develop autoimmune disorders of the central nervous system
3. Neuroendocrine–immune (NEI) circuitry from neuron–glial interactions to function: Focus on gender and HPA–HPG interactions on early programming of the NEI system
4. The reproductive system at the neuroendocrine-immune interface: focus on LHRH, estrogens and growth factors in LHRH neuron–glial interactions
5. Neurochemical, immunological and pharmacological assessments in a transgenic mouse model of the endocrine changes in depression
6. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: Glia dictates resistance versus vulnerability to neurodegeneration
7. GENDER DIFFERENCE IN THE RESPONSE OF ADULT SUBVENTRICULARZONE (SVZ) NEUROPROGENITORS IN A MOUSE MODEL OF PARKINSON’DISEASE: CRITICAL ROLE OF ESTROGEN
8. MPTP-reactive 'in situ' inflammation as a key event in the molecular cascade linking nigrostriatal injury to repair
9. Brain endothelial cells-retinal pericyte co-cultures induce PLA2 expression through activation of PKCa and MAPK/ERK cascade
10. Endothelial cell-pericyte cocultures induce PLA2 protein expression through activation of PKCα and the MAPK/ERK cascade
11. Brain endothelial cell-retinal pericyte co-cultures induce cytosolic phospholipase A2 protein expression through activation of PKCa and d isoforms and MAPK/ERK cascade
12. MAPKs mediate activation of cytosolic phospholipase A2 by amyloid β(25-35) peptide in bovine retina pericytes
13. Steroid hormone modulation of glial inducible nitric oxide synthase orchestrate neuroprotection in experimental parkinsonisin
14. Steroid hormone modulation of glial inducible bitric oxide synthase orchestrate neuroprotection in experimental parkinsonism
15. Glucorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide
16. Estrogen triggers astrocyte-microglia crosstalk in experimental Parkinsonism: Implications for neuroprotection
17. Early embryonic life exposure to dysfunctional glucocorticoid receptor(GR) programs astroglial response to inflammation via GR-nitric oxide crosstalk: Long term implications for autoimmune disorders of the CNS
18. Neuroinfiammazione, NOS inducibile e glucocorticoidi nella programmazione della vulnerabilità al danno neurodegenerativo
19. Exposure to a dysfunctional GR from early embryonic life programs the resistance to experimental autoimmune encephalomyelitis via NO-induced immunosuppression. J. Immunology
20. Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA
21. Immortalized hypothalamic luteinizing hormone-releasing hormone (LHRH) neurons induce a functional switch in the growth factor responsiveness of astroglia:involvment of basic fibroblast growth factor
22. BASIC FIBROBLAST GROWTH FACTOR (bFGF) PRIMING INCREASES THE RESPONSIVENESS OF IMMORTALIZED HYPOTHALAMIC LHRH NEURONS TO NEUROTROPHIC FACTORS
23. The neurotrophin-inducible protein 'VGF' in sensory afferents and spinal cord
24. Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
25. Basic Fibroblast Growth Factor Priming Increases the Responsiveness of Immortalized Hypothalamic Luteinizing Hormone Releasing Hormone Neurones to Neurotrophic Factors.
26. P3.048 MPTP-reactive “in situ” inflammation as a key event in the molecular cascade linking nigrostriatal injury to repair
27. Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA
28. Immortalized hypothalamic luteinizing hormone-releasing hormone (LHRH) neurons induce a functional switch in the growth factor responsiveness of astroglia: involvement of basic fibroblast growth factor
29. Circadian melatonin and young-to-old pineal grafting postpone aging and maintain juvenile conditions of reproductive functions in mice and rats
30. Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone
31. Neural stem cell transplantation in Parkinsonian mice triggers an astrocyte-dependent dopaminergic neurorestoration
32. Astrocytes from distinct nigrostriatal brain regions secrete extracellular vesicles able to mediate neuroprotection in cellular models of Parkinson's disease
33. Early embryonic life exposure to dysfunctional glucocorticoid receptor (GR) programs astroglial response to inflammation via GR-nitric oxide crosstalk: Long-term implications for autoimmune disorders of the CNS
34. Developmental consequences of hypothalamic-pituitary-adrenocortical system disruption: Impact on thymus gland maturation and the susceptibility to develop neuroimmune diseases
35. Ultrastructural and molecular characterization of astrocyte-derived extracellular vesicles from nigrostriatal brain regions: implications for dopaminergic neuroprotection
36. Neuroinflammation and oxidative stress up-regulate and translocate multidrug resistance-associated protein 1 (Mrp1) in mouse astroglia
37. Exposure to a dysfunctional glucocorticoid receptor from early embryonic life programs the resistance to experimental autoimmune encephalomyelitis via nitric oxide-induced immunosuppression
38. Glia as a turning point in the therapeutic strategy of Parkinson's disease
39. Gender, neuroendocrine-immune interactions and neuron-glial plasticity: Role of luteinizing hormone-releasing hormone (LHRH)
40. Linking nigrostriatal dopaminergic plasticity to neurogenesis, inflammation and Wnt/beta-catenin signaling : therapeutical implications for Parkinson's Disease
41. Corrigendum to “Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease” [Neurobiol. Dis. 41/2 (2011) 508–527]
42. Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?
43. Neuroendocrine-immune interactions in the control of reproduction
44. Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
45. Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1)
46. Small Extracellular Vesicles Secreted by Nigrostriatal Astrocytes Rescue Cell Death and Preserve Mitochondrial Function in Parkinson's Disease.
47. "Reframing" dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications.
48. Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease.
49. Glia-Derived Extracellular Vesicles in Parkinson's Disease.
50. Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.